Jazz Pharma Says FDA Again Defied Orphan Drug Exclusivity
By Hailey Konnath · June 22, 2023, 9:41 PM EDT
Jazz Pharma on Thursday asked a D.C. federal judge to block the U.S. Food and Drug Administration's "unlawful" approval of a rival narcolepsy treatment despite Jazz's exclusivity rights under the Orphan...
To view the full article, register now.